1-6 of 6
Monika Maas Enriquez
Close
Sort by
Journal Articles

BAY 94-9027 Provides Safe and Effective Long-Term Prophylaxis in Pediatric Patients: Results from the PROTECT VIII Kids Extension Study

Sanjay Ahuja, MD, Kathelijn Fischer, Tina Biss, Monika Maas Enriquez, Maria-Elisa Mancuso, MacGregor Steele, MD FRCPC, Maria Wang, Gili Kenet
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-140303
Published: 2020
Journal Articles

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Alfonso Iorio, Monika Maas Enriquez, Heinz Delesen, Alexander Solms, Stacy E. Croteau, Erik Berntorp
Journal: Blood
Blood (2019) 134 (Supplement_1): 3637.
https://doi.org/10.1182/blood-2019-127046
Published: 2019
Journal Articles

Improvement in Quality of Life Outcomes and Bleeding Rates among Patients Switching from On-demand FVIII to Prophylactic BAY 94-9027 in the PROTECT VIII Study

Jonathan M. Ducore, MD MPH, Shadan Lalezari, PhD, Elena Santagostino, MD PhD, Sanjay P Ahuja, MD, Monika Maas Enriquez, Claudia Tueckmantel, PhD, Mark Reding
Journal: Blood
Blood (2019) 134 (Supplement_1): 1129.
https://doi.org/10.1182/blood-2019-123947
Published: 2019
Journal Articles

Rationale for Investigator-Assigned Prophylaxis Dosing Frequency in the Leopold I Study

Thomas J. Humphries, Nikki Church, Shadan Lalezari, Lone H. Poulsen, Mia Yoon, Monika Maas Enriquez
Journal: Blood
Blood (2016) 128 (22): 4984.
https://doi.org/10.1182/blood.V128.22.4984.4984
Published: 2016
Journal Articles

BAY 81-8973, a Full-Length Recombinant Factor VIII: Results from Assay Field Study

Monika Maas Enriquez, Horst Beckmann, Yvonne Katterle, Stefan Bruns, Despina Tseneklidou-Stoeter, Steve Kitchen
Journal: Blood
Blood (2015) 126 (23): 3539.
https://doi.org/10.1182/blood.V126.23.3539.3539
Published: 2015
Journal Articles

Efficacy and Safety of Secondary Prophylactic Versus On-Demand Sucrose-Formulated Recombinant Factor VIII Treatment in Adults with Severe Hemophilia A: Results from a 13-Month Crossover Study

Peter Collins, Albert Faradji, Massimo Morfini, Monika Maas Enriquez, MD, Eduard Gorina, MD, Lawrence Schwartz, Georg Lemm, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 516.
https://doi.org/10.1182/blood.V112.11.516.516
Published: 2008